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Abstract
Background: It is uncertain whether we can predict contrast-induced nephropathy (CIN) after CT pulmonary
angiography (CTPA). This study compared the ability of a validated CIN prediction score with the Pulmonary
Embolism Severity Index (PESI) in predicting CIN after CTPA.
Methods: This cohort study involved critically ill adult patients who required a CTPA to exclude acute pulmonary
embolism (PE). Patients with end-stage renal failure requiring dialysis were excluded. CIN was defined as an elevation in
plasma creatinine concentrations > 44.2μmol/l (or 0.5 mg/dl) within 48 h after CTPA.
Results: Of the 137 patients included, 77 (51%) were hypotensive, 54 (39%) required inotropic support, and 68 (50%)
were mechanically ventilated prior to the CTPA. Acute PE was confirmed in 21 patients (15%) with 14 (10%) being
bilateral. CIN occurred in 56 patients (41%) with 35 (26%) required dialysis subsequent to CTPA. The CIN
prediction score had a good ability to discriminate between patients with and without developing CIN (Area
under the receiver-operating-characteristic (AUROC) curve 0.864, 95% confidence interval [CI] 0.795–0.916) and
requiring subsequent dialysis (AUROC 0.897, 95% CI 0.833–0.942) and was better than the PESI in predicting both
outcomes (AUROC 0.731, 95% CI 0.649–0.804 and 0.775, 95% CI 0.696–0.842, respectively). A CIN risk score > 10
and 12 had an 82.1 and 85.7% sensitivity and 81.5 and 78.4% specificity to predict subsequent CIN and dialysis,
respectively. The CIN prediction model tended to underestimate the observed risks of dialysis, but this was improved
after recalibrating the slope and intercept of the original prediction equation.
Conclusions: The CIN prediction score had a good ability to discriminate between critically ill patients with and
without developing CIN after CTPA. Used together for critically ill patients with suspected acute PE, the CIN
prediction score and PESI may be useful to inform clinicians when the benefits of a CTPA scan will outweigh its
potential harms.
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Background
Venous thromboembolism (VTE), including deep vein
thrombosis (DVT) and pulmonary embolism (PE), is one
of the most preventable causes of death and morbidity in
hospitalised patients [1, 2]. The incidence of asymptomatic
VTE, including PE, in critically ill or injured patients is
very high despite anticoagulant prophylaxis [3]. In one
cohort study, up to 10% of the patients already had unsus-
pected DVT at the time of ICU admission [4] and PE
accounted for about 1% of all emergency intensive care
unit (ICU) admissions [5].
For patients presenting with non-specific symptoms and
signs of PE, including chest pain, respiratory failure, or
hypotension, a computed tomography pulmonary angiog-
raphy (CTPA) is often needed to confirm or exclude a
life-threatening acute PE. In addition to a small risk of
anaphylaxis, use of radiocontrast can induce acute kidney
injury or contrast-induced nephropathy (CIN), especially
in patients with pre-existing renal impairment. Although
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some retrospective observational studies have sug-
gested that CIN may have been overemphasised or
may not even exist in patients without multiple risk
factors for CIN [6, 7], recent randomised controlled
trials did demonstrate that risk of CIN in patients at
extreme risk for CIN can be attenuated with aggres-
sive interventions [8, 9]. While most patients who
develop CIN will not require dialysis and will recover
without permanent complications, there is an increas-
ing evidence to suggest that CIN can induce long-
term renal damage and mortality in high-risk patients.
In the study by Mehran et al., the risks of requiring
dialysis for CIN and 1-year mortality were 13 and
33% for those with multiple risk factors for CIN com-
pared to only < 0.5 and 2% for those with the lowest
risk of developing CIN, respectively [10]. The clinical
significance of CIN was further confirmed by a recent
study which showed that nearly one third of the in-
hospital mortality after percutaneous coronary inter-
vention was attributable to CIN, and one death could
be potentially prevented by preventing nine cases of
CIN [11].
The decision to proceed with a CTPA to exclude a
life-threatening acute PE in patients with multiple risk
factors for CIN is difficult. Theoretically, a CTPA will be
justifiable provided its benefits outweigh its harms. In
practice, to balance the benefits and risks of a radiocon-
trast study for critically ill patients is challenging. Firstly,
in critically ill patients presenting with symptoms and
signs of a life-threatening PE, opportunities to use
prophylactic measures against CIN, including aggressive
intravenous hydration, are limited [12–15]. Secondly,
many risk factors for CIN, including heart failure,
hypotension, and increasing age, are also risk factors for
mortality in acute PE [10, 16, 17], suggesting that
patients who are most at risk of dying from acute PE
are, perhaps, also most at risk of developing CIN after a
CTPA scan [18, 19].
Data on prediction of CIN are largely derived from
cardiology patients who undergo radiological interven-
tions [10]; whether any existing CIN prediction
models can reliably predict CIN after a CTPA, espe-
cially when applied to the critically ill, remains uncer-
tain. We hypothesised that in critically ill patients
with suspected acute PE, their risk of CIN after
CTPA can be estimated by the CIN prediction model
developed by Mehran et al. [10]. In this study, we
assessed the accuracy of the CIN risk prediction score
in a cohort of critically ill patients who needed a
CTPA to exclude acute PE. In addition, because Pul-
monary Embolism Severity Index (PESI) shares a
number of predictors with the CIN risk prediction
score, we also wanted to compare the ability of these
two prediction models in predicting CIN, as well as
mortality, in critically ill patients with suspected acute
PE requiring a CTPA scan [16].
Methods
All critically ill adult patients at Royal Perth Hospital
intensive care unit who required an urgent CTPA scan
to exclude acute PE, between January 2013 and Septem-
ber 2017, were included. The data analysed included age,
gender, with factors that were needed to estimate risks
of CIN and dialysis, including hypotension, use of intra-
aortic balloon pump, congestive heart failure, anaemia,
diabetes mellitus, and baseline renal function before the
CTPA (http://tools.farmacologiaclinica.info/index.php)
[10]. In addition, the information needed to calculate the
PESI include underlying cancer, chronic lung disease,
hypoxaemia, tachypnoea, hypothermia, altered mental
state, and tachycardia were also collected and analysed
[16]. In this study, patients with end-stage renal failure
requiring long-term dialysis or patients who had a con-
trast CT chest scan not specifically tailored to look for
acute PE were excluded.
Similar to other studies on CIN, CIN was defined as
an elevation in plasma creatinine concentrations >
44.2μmol/l (or 0.5 mg/dl) within 48 h after the CTPA in
this study—the same time frame used in the original
study by Mehran et al. [10] which was not significantly
different from the time frame (1 to 4 days) used in most
recent interventional and observational studies on CIN
[6–9]. As for the requirement for dialysis, this was cap-
tured until hospital discharge. The study centre used be-
tween 50 and 75 ml of intravenous radiocontrast (either
Ultraject Optiray®350: active ingredient ioversol or
Omnipaque-350: active ingredient iohexol) for all CTPA
scans. All data used in this retrospective cohort study
were already collected for administrative purposes, and
the clinicians who made the decision to initiate dialysis
for the study patients were blinded to the Mehran’s pre-
dicted risk of CIN but not the clinical risk factors for
CIN. All procedures performed in this study were in ac-
cordance with the ethical standards of the institutional
and national research committee and with the 1964
Helsinki declaration and its later amendments or com-
parable ethical standards. Because the study only used
clinical data that were already collected for administra-
tive purposes, formal patient consent was considered
not necessary, and this study was registered with the
Royal Perth Hospital Clinical Safety and Quality Unit
(No: 22233) with an intention for peer-review
publication.
Statistical analyses
Categorical and continuous variables with skewed distri-
butions were analysed by Chi-square and Mann Whitney
tests, respectively. Area under the receiver-operating-
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characteristic (AUROC) curve was used to assess
whether the existing CIN prediction score and PESI
were useful in discriminating between patients with and
without CIN and, similarly, for requiring subsequent dia-
lysis. In this study, an AUROC > 0.8, between 0.7 and
0.8, and < 0.7 were defined as good, satisfactory, and un-
satisfactory, respectively. Sample size (N = 124) was de-
termined by assuming (a) 95% power, (b) the Mehran’s
CIN prediction model had an AUROC of 0.8 to predict
CIN and the AUROC for PESI was 0.7, and (c) the risk
of CIN was 25% after CTPA in the critically ill.
Calibration of the CIN prediction score and PESI was
assessed by the Hosmer-Lemeshow Chi-square statistics
and by comparing the observed and predicted risks in a
calibration plot. If the CIN prediction score was not
well-calibrated, an attempt was made to recalibrate the
prediction equation’s slope and intercept using logistic
regression to see if this could improve the calibration of
the score without using different or additional covari-
ates. Missing data for any of the predictors needed for
both prediction models were considered as normal to
avoid over-inflating the prediction ability of the models.
All statistical analyses were performed by SPSS for Win-
dows (version 24.0, IBM, USA) and MedCalc for Win-
dows (version 12.5, Ostend, Belgium), and a two-tailed
α-error of < 5% was taken as significant. The TRIPOD
Checklist for this study is listed in Additional file 1:
Table S1, and non-identifiable data will be available by
contacting the corresponding author.
Results
Characteristics of the study patients
Of the 141 patients who required a CTPA to exclude
acute PE during the study period, 137 patients who did
not have end-stage renal failure were included for fur-
ther analysis. Prior to the CTPA, 77 patients (51%) were
hypotensive, 54 (39%) required inotropic support, and
68 (50%) were mechanically ventilated. Acute PE was
confirmed in 21 patients (15%) with 14 (10%) being bi-
lateral. Pneumonia was diagnosed in 66 (48%) patients
by the CTPA scan. CIN within 48 h after CTPA
occurred in 56 patients (41%), with 35 patients (26%) re-
quired subsequent dialysis during the same hospital stay.
The characteristics and outcomes of the study cohort
are described in detail in Table 1, and no patients had
missing data on the risk factors needed to estimate the
CIN prediction score and PESI, occurrence of CIN, and
requirement for dialysis.
Predicting CIN, dialysis, and mortality
The CIN prediction score (median 9, interquartile range
4–16) had a good ability to discriminate between pa-
tients with and without developing CIN within 48 h after
the CTPA (AUROC 0.864, 95% confidence interval [CI]
Table 1 Characteristics and outcomes of the study patients
(N = 137)
Variables Median (interquartile range)
unless stated otherwise
Age, years 53 (43–69)
Male, no. (%) 97 (70.8)
Comorbidities, no. (%):
- Diabetes mellitus 41 (30)
- Cancer 28 (20)
- Chronic lung disease 33 (24)
- Congestive heart failure 56 (41)
Baseline organ support therapy, no. (%):
- Inotropes 54 (39)
- Mechanical ventilation 68 (50)
- Intra-aortic balloon pump 2 (2)
Baseline physical signs, no. (%):
- Tachycardia (> 110 bpm) 68 (50)
- Hypotension (< 100 mmHg) 70 (51)
- Tachypnoea (> 30 breaths/min) 77 (56)
- Hypothermia (< 36C°) 19 (14)
- Altered mental state 38 (28)
- Hypoxaemia (SaO2 < 90%) 104 (76)
Haemoglobin concentrations, d/L 110 (89–131)
Haematocrit, % 33 (27–40)
Plasma creatinine conc., μmol/L 89 (64–137)
CIN risk score 9 (4–16)
Pulmonary Embolism Severity Index 144 (99–190)
APACHE II score 23 (17–31)
Outcomes:
Maximum creatinine conc. within 48 h after
CTPA, μmol/L
92 (65–178)




Acute pulmonary embolism (PE),
no. (%)
21 (15)
Bilateral PE, no. (%) 14 (10)
Pneumonia on CTPA, no. (%) 66 (48)
Hospital mortality, no. (%) 69 (50)
Length of ICU stay, days 6 (3–16)
Length of hospital stay, days 13 (7–26)
CIN prediction score > 10: PPV
for CIN, %
75.5
CIN prediction score > 10: NPV
for CIN, %
86.6
CIN prediction score > 12: PPV for dialysis, % 58.2
CIN prediction score > 12: NPV for dialysis, % 94.0
APACHE Acute Physiology and Chronic Health Evaluation, CTPA CT
pulmonary angiography, CIN contrast-induced nephropathy: defined as
an elevation in plasma creatinine concentrations > 44.2μmol/l (or 0.5 mg/dl)
within 48 h after CTPA, ICU intensive care unit, NPV negative predictive
value, PPV positive predictive value, SaO2 arterial oxygen saturation
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0.795–0.916), which was better than the PESI (AUROC
0.731, 95% CI 0.649–0.804; difference in AUROC 0.133,
p = 0.001) (Fig. 1) or using baseline plasma creatinine
concentrations alone without the other components of
the CIN score (AUROC 0.732, 95% CI 0.641–0.823)
(Fig. 2). A CIN risk score > 10 and 12 had an 82.1 and
85.7% sensitivity and 81.5 and 78.4% specificity to pre-
dict subsequent CIN (Youden index J 0.64, 95% CI
0.50–0.74) and dialysis (Youden index J 0.64, 95% CI
0.44–0.74), respectively.
Similarly, the CIN prediction score was also better
than the PESI in discriminating between patients who
required subsequent dialysis and those who did not
(AUROC 0.897, 95% CI 0.833–0.942 vs. 0.775, 95% CI
0.696–0.842, respectively; difference in AUROC 0.121,
p = 0.009) (Fig. 3).
The calibration plots showed that the CIN prediction
score underestimated both the observed risks of CIN
(Hosmer-Lemeshow Chi-square = 9.4, p = 0.009) and dia-
lysis (Hosmer-Lemeshow Chi-square = 15.3, p = 0.001)
(Figs. 4 and 5). After recalibration of the slope and inter-
cept of the prediction equation, the CIN predicted risks
of requiring dialysis after a CTPA were more closely re-
lated to the observed risks of dialysis (recalibrated CIN
risk = 1/(1 + e4.888−CIN score × 0.297) (Fig. 6).
Despite not all study patients had a confirmed acute
PE, the PESI still had a satisfactory ability and indeed far
Fig. 1 Areas under the receiver-operating-characteristic (AUROC) curve
of the Pulmonary Embolism Severity Index (PESI) and contrast-induced
nephropathy (CIN) prediction score to predict risk of CIN. CIN was
defined as an elevation in plasma creatinine concentrations >
44.2μmol/l (or 0.5 mg/dl) within 48 h after computed tomography
pulmonary angiography
Fig. 2 Areas under the receiver-operating-characteristic (AUROC)
curve of the contrast-induced nephropathy (CIN) prediction score
and baseline plasma creatinine concentration to predict risk of CIN.
CIN was defined as an elevation in plasma creatinine concentrations
> 44.2μmol/l (or 0.5 mg/dl) within 48 h after computed tomography
pulmonary angiography
Fig. 3 Areas under the receiver-operating-characteristic (AUROC)
curve of the Pulmonary Embolism Severity Index (PESI) and
contrast-induced nephropathy (CIN) prediction score to predict
risk of requiring dialysis
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better ability than the CIN prediction score to discrimin-
ate between survivors and non-survivors (AUROC 0.794,
95% CI 0.716–0.858 vs. 0.625, 95% CI 0.538–0.706; dif-
ference in AUROC 0.169, p = 0.001) (Fig. 7). CIN predic-
tion score and PESI were, however, both unsatisfactory
in predicting the presence of PE on the CTPA (both
AUROC < 0.6).
Discussion
This study showed that CIN (41%) and dialysis (26%) after a
CTPA scan were not rare in the critically ill with a suspected
life-threatening acute PE. In patients with unstable vital
signs and physiology requiring multiple organ support, the
CIN prediction score had a good ability to discriminate be-
tween patients with and without developing CIN (AUROC
0.864) and requiring dialysis (AUROC 0.897) subsequently
and was better than the PESI in predicting both outcomes.
A CIN risk score > 10 and 12 had an 82.1 and 85.7% sensi-
tivity and 81.5 and 78.4% specificity to predict subsequent
CIN and dialysis, respectively. However, the CIN prediction
score tended to underestimate the risks of CIN and dialysis
and was also inferior to the PESI in predicting mortality in
the critically ill with suspected PE. These results have some
clinical implications and require further discussion.
Fig. 4 The relationship between the contrast-induced nephropathy (CIN) prediction score’s predicted and observed risks of CIN
Fig. 5 The relationship between the contrast-induced nephropathy (CIN) prediction score’s predicted and observed risks of dialysis
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First, despite an increasing awareness of the importance
of VTE in the critically ill, PE remains as one of the fre-
quently missed diagnoses—identified only in autopsies
[20–23]. Because the pre-test probability of VTE in the
critically ill is high, d-dimers are not useful and CTPA has
practically become the gold standard to confirm or
exclude a life-threatening acute PE [20]. This practice is
further supported by the fact that a CTPA can also
evaluate the right ventricular size, which reflects the sever-
ity of acute PE. In addition, a CTPA may provide import-
ant information on alternative differential diagnoses such
as pneumonia. Nevertheless, our results suggest that there
is a risk of CIN associated with any radiocontrast studies,
including a CTPA scan, in the critically ill. It is possible
that the deteriorations in renal function after a CTPA in
some of our patients could occur regardless of whether
radiocontrast had been used, or at least in part, if not
purely due to the natural progression of a life-threatening
illness. The differential ability of the CIN prediction score
and PESI in predicting CIN and mortality suggests that
the severity of illness alone may not fully explain the risks
of renal dysfunction and dialysis after a CTPA scan. PESI
and CIN prediction score do share some similar risk
factors (such as age, congestive heart failure, and
hypotension), but there are also factors in the CIN predic-
tion score that are distinct from the PESI, including
diabetes mellitus, anaemia, and pre-existing renal impair-
ment [10, 18, 19]. As such, we can argue that radiocon-
trast was likely to play a contributing role in inducing the
increases in plasma creatinine concentrations in our pa-
tients, especially in those with multiple risk factors for
CIN [10, 18, 19].
Our results also suggest that the CIN prediction score
and PESI may also have complementary roles in deter-
mining the balance between benefits and harms of a
CTPA in a patient with suspected acute PE. Theoretic-
ally, a CTPA will be justifiable if the predicted risk of
mortality by the PESI is higher than the predicted risk of
requiring dialysis by the CIN prediction score in any pa-
tients with symptoms and signs of acute PE. Conversely,
if the CIN prediction score’s predicted risk of requiring
Fig. 6 The relationship between the contrast-induced nephropathy (CIN) prediction score’s predicted and observed risks of requiring dialysis after
recalibrating the prediction equation’s slope and intercept
Fig. 7 Areas under the receiver-operating-characteristic (AUROC)
curve of the Pulmonary Embolism Severity Index (PESI) and
contrast-induced nephropathy (CIN) prediction score to predict
risk of hospital mortality
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dialysis is much higher than the predicted risk of mortal-
ity by the PESI (when the CIN risk score is > 16 and
PESI is < 126) (Fig. 8), perhaps an alternative way to
diagnose or exclude an acute PE, possibly by a combin-
ation of tests—such as transoesophageal echocardiog-
raphy, lower limb venous ultrasonography, and
ventilation-perfusion scan—should be seriously consid-
ered in reducing the long-term consequences of CIN
[10, 24]. However, a delay in doing a CTPA scan to allow
aggressive intravenous hydration or other forms of CIN
prophylaxis does not confer substantial benefits in redu-
cing CIN after CTPA in an acute care setting [25, 26].
Second, our study showed that the CIN prediction
score had a good discriminative ability but was not well-
calibrated in predicting both CIN and dialysis after a
CTPA in the critically ill. It should be noted that our
primary results—AUROC, sensitivity, and specifici-
ty—are known to be not affected by prevalence (or pre-
test probability) of the outcome of interest. In addition,
after recalibration of the intercept and slope of the exist-
ing CIN prediction equation, the predicted risks of re-
quiring dialysis appeared to match the observed risks
much better (Fig. 7). This result suggests that the covari-
ates used in the CIN prediction are largely ‘good or
valid’ predictors for CIN in the critically ill, even though
they are derived from cardiology patients. Hence, further
refinement and recalibration of the CIN prediction score
for patients who require a CTPA will be feasible, and
relatively straightforward, by a prospective multicentre
cohort study. Using a conservative rule of one covariate
per ten outcomes and assuming an incidence (or pre-
test probability) of CIN is 20% (or 10%), a sample
size > 600 (or 1200) patients will be needed to de-
velop a CIN prediction model with 12 predictors for
the critically ill which can then be validated with a
similar or larger size study.
Finally, we need to acknowledge the limitations of this
study. Although the CIN prediction score has included a
number of risk factors for renal dysfunction after adminis-
tration of radiocontrast, there are other risk factors that
might also be important, including use of nephrotoxic
drugs and presence of infection. The significance of these
risk factors in predicting CIN should be considered in de-
veloping a CIN prediction model for patients undergoing a
CTPA scan. With a relatively small sample size, we were
unable to test the relative importance of each risk factor
contained in the CIN prediction score, both in predicting
CIN as well as the presence of PE and its associated mortal-
ity. As such, a large prospective multicentre study will be
essential to improve our understanding on when, and in
whom, a CTPA will be most beneficial.
Conclusions
In summary, CIN and dialysis were not rare in critic-
ally ill patients who had unstable vital signs after
using CTPA scan to exclude a life-threatening acute
PE. Despite only derived from cardiology patients, the
CIN prediction score had a good ability to discrimin-
ate between patients with and without developing
CIN and requiring dialysis after an urgent CTPA scan
and indeed was better than the PESI in predicting
both adverse renal outcomes. Further research is,
however, needed to improve the calibration of the
current CIN prediction score or reconstruct an even
Fig. 8 The situations when contrast-induced nephropathy (CIN) prediction score’s predicted risk of dialysis exceeds the Pulmonary Embolism Severity
Index (PESI)’s predicted risk of mortality
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more accurate prediction score in predicting CIN and
dialysis in the critically ill who require different types
of radiocontrast study. Used together for critically ill
patients with suspected acute PE, the CIN prediction
score and PESI may be useful to inform clinicians
when the benefits of a CTPA scan will outweigh its
potential harms.
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